NOGCA 2021 Short Report: Palliative Radiotherapy for Oesophago-Gastric Cancer

The 2021 short report from the National Oesophago-Gastric Cancer Audit evaluates the use of evidence-based radiotherapy regimens for patients with oesophago-gastric cancer under a palliative treatment plan. This collaborative national clinical audit is run by several UK and Ireland medical associations and is part of the National Clinical Audit and Patient Outcomes Programme. The report contains aggregated findings and does not include individual patient information or identifiable data.

Use Cases

• Benchmarking palliative care practices based on the audit's evaluation of radiotherapy regimen usage.
• Analyzing adherence to evidence-based treatment guidelines mentioned in the report's scope.
• Supporting NHS service improvement initiatives based on the audit's stated aim.
• Studying national clinical audit methodologies for oesophago-gastric cancer care.

Strengths

• Report is part of a formal national clinical audit program (NCAPOP) managed by the Healthcare Quality Improvement Partnership.
• Collaboratively produced by multiple authoritative medical societies and NHS Digital.
• Data is anonymized and contains no individual patient information or identifiable data.
• Released under a permissive CC-BY-4.0 license.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is presented in a PDF report format, which may require extraction for computational analysis.

Provenance

Source

Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG), Royal College of Radiologists, NHS Digital, and the Clinical Effectiveness Unit at the Royal College of Surgeons of England.

Collection Method

National clinical audit.

Time Range

2021 report, but specific data collection period is unknown.

Freshness

Last update date is unknown; freshness unverified.

Geography

Great Britain and Ireland, based on the participating organizations.